We are a leading healthcare campus encompassing all fields of health: from healthcare and research to teaching and management.
Professionalism, commitment and research by professionals on the Campus are the key elements in offering patients excellent care.
We are committed to research as a tool to provide solutions to the daily challenges we face in the field of medical healthcare.
We generate, transform and transmit knowledge in all areas of the health sciences, helping to train the professionals of the future.
We are defined by our vocation for communication. We invite you to share everything that happens at Vall d'Hebron Barcelona Hospital Campus, and our doors are always open.
Hospital donations
Research donations
Speaker: Stefan Hümmer, main researcher Translational Molecular Pathology (VHIR)
Abstract: Therapy resistance remains a main cause of therapeutic failure in cancer treatment. Immunotherapy has opened a new avenue in oncology, but is only effective in a small fraction of patients. Therapy resistance and immune evasion critically rely on the activation of stress response pathways. Those pathways activate the kinases MNK1/2 which uniquely regulate eIF4E. Phosphorylation of eIF4E is associated worse prognosis in several tumors and targeting MNKs has evolved as strategy in oncology.
CV summary: Stefan Hümmer obtained his PhD in Biology in 1999 from the Ludwig Maximilian University in Munich. During his scientific carrier, he was working at the Max-Planck Institute in Munich (PhD), the Biozentrum in Basel and the PRBB in Barcelona (post-doctoral fellow). After extending his scientific horizon on the work with genetic model organisms, he returned to his longstanding interest in small molecule inhibitors, either as tools to study basic cellular functions, or as potential drug targets. In this regard, his research has resulted in several research publications as first and/or corresponding author and four patent applications. In his function as senior researcher, he is responsible for the research laboratory “Translational Molecular Pathology” of Santiago Ramon y Cajal at VHIR since 2017. He is member of the research network in oncology (CIBER, ICSIII) and is currently hired as postdoctoral researcher for the project MNKImmunoOnco through the research program of “Plan Complementario (IBEC)”.
Host: Dr. Santiago Ramón y Cajal, head of group Translational Molecular Pathology (VHIR)
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights". Operated by: Vall d’Hebron University Hospital Foundation – Research Institute. Purpose: Manage the user’s contact information. Legitimisation: Express acceptance of the privacy policy. Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use. Source: The interested party themselves.